KINDSTAR GLOBALGENE TECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.6 HKD | +2.56% |
|
+4.58% | -4.76% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Kindstar Globalgene Technology Inc is a China-based investment holding company principally engaged in the provision of clinical testing services. The Company operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctorsâ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.6
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.76% | 190M | |
| -17.89% | 8.36B | |
| +40.38% | 3.6B | |
| -39.11% | 2.73B | |
| -8.06% | 2.47B | |
| -7.35% | 2.32B | |
| -11.56% | 1.77B | |
| -18.68% | 1.55B | |
| -40.66% | 1.22B | |
| +7.56% | 1.09B |
- Stock Market
- Equities
- 9960 Stock
- News Kindstar Globalgene Technology, Inc.
- Kindstar Globalgene Technology Amends Payment Terms for Stake Deal in Xinjiang Kindstar Yijiali Medical Laboratory
